---
title: "Moderna wins EU contract for RSV vaccine supply"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292189866.md"
datetime: "2026-07-09T11:15:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292189866.md)
  - [en](https://longbridge.com/en/news/292189866.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292189866.md)
generator: "portal-rs"
---

# Moderna wins EU contract for RSV vaccine supply

July 9 (Reuters) - Moderna (MRNA.O) said on Thursday it has secured a European Commission contract to supply its respiratory syncytial virus vaccine to six countries in the region.

Here are the details:

-   The agreement gives the participating countries - Austria, Denmark, Ireland, Luxembourg, Norway and Portugal - access to up to 24 million doses of the vaccine over as many as four years, the company said.
-   The vaccine, mRESVIA, will be supplied in a ready-to-use, single-dose pre-filled syringe, making administration easier for healthcare professionals, Moderna said.
-   The company had a similar joint procurement framework agreement with the European Commission for COVID-19 vaccines last year.
-   mRESVIA is authorized in the European Union to prevent lower respiratory tract disease caused by RSV in adults.
-   RSV is a common respiratory virus that causes seasonal infections such as the flu and is a leading cause of pneumonia and death in infants and older adults.
-   Moderna has four approved mRNA vaccines for respiratory infections, including a combined influenza and COVID-19 vaccine authorized in Europe.

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md)

## Related News & Research

- [Moderna stock soars on cancer vaccine success](https://longbridge.com/en/news/296405393.md)
- [MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure](https://longbridge.com/en/news/296603043.md)
- [Moderna’s 177% Surge Has Investors Asking What Comes Next](https://longbridge.com/en/news/296610623.md)
- [Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test](https://longbridge.com/en/news/296382081.md)
- [REG - GraniteShares Fin. Graniteshares 3x S M Granite 3X shrt Mod£ - 3SMO - SOL3 - Early termination notice](https://longbridge.com/en/news/296371392.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**